相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice
Asim Saha et al.
BLOOD (2022)
CD33-directed immunotherapy with third-generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33-edited acute myeloid leukemia and hematopoietic stem and progenitor cells
Yi Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques
Aisha A. AlJanahi et al.
MOLECULAR THERAPY (2022)
Efficient polymer nanoparticle-mediated delivery of gene editing reagents into human hematopoietic stem and progenitor cells
Rkia El-Kharrag et al.
MOLECULAR THERAPY (2022)
Multiplex CRISPR/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations
Clare Samuelson et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Pseudogene-Mediated Gene Conversion After CRISPR-Cas9 Editing Demonstrated by Partial CD33 Conversion with SIGLEC22P
Benjamin C. Shaw et al.
CRISPR JOURNAL (2021)
Effective Multi-lineage Engraftment in a Mouse Model of Fanconi Anemia Using Non-genotoxic Antibody-Based Conditioning
Meera A. Srikanthan et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation
Agnieszka Czechowicz et al.
NATURE COMMUNICATIONS (2019)
OPTIMIZATION OF CRISPR-CAS9 KNOCK-OUT OF CD33 IN HUMAN HEMATOPOIETIC STEM / PROGENITOR CELLS FOR ALLOGENEIC TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
K. D. Cummins et al.
CYTOTHERAPY (2019)
Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies
Florence Borot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates
Olivier Humbert et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR/Cas9-deletion of CD33 exon 2
Olivier Humbert et al.
LEUKEMIA (2019)
Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemia
Bo Yu et al.
BIOMARKER RESEARCH (2019)
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
Miriam Y. Kim et al.
CELL (2018)
A Nonhuman Primate Transplantation Model to Evaluate Hematopoietic Stem Cell Gene Editing Strategies for beta-Hemoglobinopathies
Olivier Humbert et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques
H. B. Zheng et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage
Nicole M. Gaudelli et al.
NATURE (2017)
A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates
Stefan Radtke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease
Allistair Abraham et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Gemtuzumab ozogamicin for acute myeloid leukemia
Frederick R. Appelbaum et al.
BLOOD (2017)
At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT
Courtney D. Fitzhugh et al.
BLOOD (2017)
Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy
Jennifer E. Adair et al.
NATURE COMMUNICATIONS (2016)
Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDS
Christopher W. Peterson et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
The past and future of CD33 as therapeutic target in acute myeloid leukemia
George S. Laszlo et al.
BLOOD REVIEWS (2014)
Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates
Brian C. Beard et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors
Grant D. Trobridge et al.
BLOOD (2008)
Differences in CD33 intensity between various myeloid neoplasms
I Jilani et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2002)
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia
MC Walters et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
分享论文
